Works matching IS 13524585 AND DT 2016 AND VI 22 AND IP 9
Results: 17
Neurofilament in CSF—A biomarker of disease activity and long-term prognosis in multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – Commentary.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – YES.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1126, doi. 10.1177/1352458516650526
- By:
- Publication type:
- Article
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1154, doi. 10.1177/1352458516645206
- By:
- Publication type:
- Article
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – NO.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1128, doi. 10.1177/1352458516643397
- By:
- Publication type:
- Article
Astrocytes in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1114, doi. 10.1177/1352458516643396
- By:
- Publication type:
- Article
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1235, doi. 10.1177/1352458516638558
- By:
- Publication type:
- Article
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1231, doi. 10.1177/1352458516630823
- By:
- Publication type:
- Article
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1174, doi. 10.1177/1352458515615225
- By:
- Publication type:
- Article
Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1144, doi. 10.1177/1352458515614407
- By:
- Publication type:
- Article
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1215, doi. 10.1177/1352458515614092
- By:
- Publication type:
- Article
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1133, doi. 10.1177/1352458515614091
- By:
- Publication type:
- Article
Prevalence of neuropathic pain in early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1224, doi. 10.1177/1352458515613643
- By:
- Publication type:
- Article
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1202, doi. 10.1177/1352458515613641
- By:
- Publication type:
- Article
Cortical relapses in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1184, doi. 10.1177/1352458514564483
- By:
- Publication type:
- Article
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1192, doi. 10.1177/1352458515613165
- By:
- Publication type:
- Article
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing–remitting multiple sclerosis (the ARIANNA study).
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1163, doi. 10.1177/1352458515611222
- By:
- Publication type:
- Article